New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an increased risk of rare eye conditions.

The morbidly obese members of the so-called National Association to Advance Fat Acceptance (NAAFA) have predictably come out ...

Researchers uncover ‘dangerous’ threat of global scam operation affecting millions as health regulators warn fraudulent ...

Drugs such as Ozempic, Wegovy and Mounjaro (known as semaglutide and tirzepatide) have changed the way clinicians manage ...

One study found a modest risk of developing non-arteritic anterior ischaemic optic neuropathy (NAOIN), a rare eye condition ...

Three new studies suggest that Ozempic and related diabetes and weight loss drugs may help protect the brain from strokes.

Ozempic’s weight loss benefits might come at the cost of muscle strength, even if muscle size remains relatively stable. This raises significant concerns for older adults, who are already at risk for ...

Doctors and many patients say GLP-1 drugs can help solve the growing problem of obesity. But some bristle at the thought that obesity is a problem at all.

A new study in mice has found that muscle loss associated with weight loss from GLP-1 medications like Ozempic may not be as ...

Past research has found that Ozempic may have more health beyond weight loss and weight management. Now, three new studies ...

GLP-1 drugs often cause weight loss because they mimic the GLP-1 hormone the body naturally produces after eating. Appetite decreases as users feel fuller for longer. The meds are prescribed to people ...

Could popular diabetes and weight loss drugs like Ozempic actually protect your brain from stroke damage, or prevent strokes ...